References
- Cotman C. W., Iversen L. L. Excitatory amino acids in the brain focus on NMDA receptors. Trends in Neurosci. 1987; 10: 263–265
- Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–634
- Dewart D., Chalmers D. T., Shand A., Graham D. I., McCulloch J. Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum. Ann. Neurol. 1990; 28: 805–810
- Young A. B., Greenamyre J. T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I., Penny J. B. NMDA receptor losses in putamen from patients with Huntington's disease. Science 1988; 981–983
- Patel S., Chapman A. G., Graham J. L., Meldrum B. S., Frey P. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (D-CPP-ene) in a rodent and primate model of reflex epilepsy. Epilepsy Res. 1990; 7: 3–10
- Morris R. G. M., Anderson E., Lynch G. S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist. Nature 1986; 319: 774–776
- Hartvig P., Valtysson J., Antoni G., Westerberg G., Långström B., Moberg E. R., Oye I. Brain kinetic of (R)- and (S)-[N-methyl-11C]ketamine in the Rhesus monkey studied by Positron Emission Tomography (PET). Nucl. Med. Biol. 1994; 21: 927–934
- Blin J., Denis A., Yamaguchi T., Crouzel C., MacKenzie E. T., Baron J. C. PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand. Neurosci. Lett 1991; 121: 183–186
- Schneider E., Schneider P. A., Clemens R., Balzereit F., Fuenfgeld E.-W, Haase H. J. Effects of oral memantine on symptoms of Parkinson's disease, Dtsch Med. Wshr. 1994; 109: 987–994
- Samnick S., Ametamey S., Gold M. R., Schubiger P. A. Synthesis and preliminary in vitro evaluation of a new memantine derivative l-amino-3-[18F]fluoro-methyl-5-methyl-adamantane: A potential ligand for mapping the N-Methyl-D-Aspartate receptor complex. J. Lab. Comp. Radiopharm. 1997; 39: 241–250
- Coenen H. H., Klatte B., Knöchel A., Schüller M., Stöcklin G. Preparation of N. C. A. [17-18F]-Fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination. J. Label. Comp. Radiopharm. 1986; 23: 455–466
- Chi D. Y., Kilbourn M. R., Katzenellenbogen J. A., Brodack J. W., Welch M. J. Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives. Appl. Radiat. Isot. 1986; 37: 1173–1180
- Winchell H. S., Baldwin R. S., Lin T. H. Development of I-123 labelled amines for brain studies:localozation of I-123 iodophenylalkyl amines in rat brain. J. Nucl. Med. 1980; 21: 940–946
- Quarum M. L., Parker J. D., Keana J. F. W., Weber E. (+)-[3H]MK-801 binding sites in postmortem human brain. J. Neurochem. 1990; 54: 1163–1168
- Wong E. H. F., Knight A. R., Woodruff G. N. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 1988; 50: 274–281
- Mash D. C., Zebatian C. P. Sigma receptors are associated with cortical limbic areas in the primate brain. Synapse 1992; 12: 195–205
- Weissman A. D., Su T. P., Hedreen J. C., London E. Sigma receptors in post mortem human brains. J. Pharm. Exp. Ther. 1988; 247: 29–33
- Largent B. L., Grundlach A. L., Snyder S. H. Psychotomimetic opiate receptors labelled and visualized with (+)[3H]-(3-hydroxyphenyl)-N-(l-propyl)piperidine. Proc. Nat. Acad. Sci. USA 1984; 81: 4983–4987